Calorie Counting for PCOS Management with GLP-1 Therapy: A Comprehensive Guide
Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that affects millions of women worldwide. It is characterized by irregular menstrual cycles, cysts on the ovaries, and excess androgen levels. Weight management is an essential component of PCOS management, and GLP-1 therapy has emerged as a promising treatment option. In this article, we will explore the role of calorie counting in PCOS management with GLP-1 therapy.What are GLP-1 Receptor Agonists?
GLP-1 receptor agonists (GLP-1RAs) are a type of medication that mimics the action of glucagon-like peptide-1 (GLP-1), a hormone that regulates insulin secretion and glucose metabolism. GLP-1RAs, such as semaglutide and liraglutide, have been shown to improve insulin sensitivity, reduce appetite, and support weight loss in women with PCOS.The Role of Calorie Counting in PCOS Management with GLP-1 Therapy
